VickieHugMD

PubMed

• Regulation of insulin receptor gene expression. Cell cycle-mediated effects on insulin receptor mRNA stability.
  Levy, J. R., Hug, V.> ;J Biol Chem. 1992 Dec 15
• Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?
  Buzdar, A. U., McNeese, M. D., Hortobagyi, G. N., Smith, T. L., Kau, S., Fraschini, G., Hug, V., Ellerbroek, N., Holmes, F. A., Ames, F.> ;Cancer. 1990 Feb 1
• Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
  Koh, E. H., Buzdar, A. U., Ames, F. C., Singletary, S. E., McNeese, M. D., Frye, D., Holmes, F. A., Fraschini, G., Hug, V., Theriault, R. L.> ;Cancer Chemother Pharmacol. 1990
• Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone.
  Hug, V., Kau, S., Hortobagyi, G. N., Jones, L.> ;Br J Cancer. 1991 Mar
• Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.
  Buzdar, A. U., Kau, S. W., Hortobagyi, G. N., Ames, F. C., Holmes, F. A., Fraschini, G., Hug, V., Theriault, R. L., McNeese, M. D., Singletary, S. E.> ;Cancer. 1992 Jan 15
• The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.
  Hug, V., Polyzos, A., Tucker, S., Thames, H.> ;Br J Cancer. 1993 Feb
• Nuclear protein-binding analysis of a GC-rich insulin-receptor promoter regulatory region.
  Levy, J. R., Hug, V.> ;Diabetes. 1993 Jan
• The results of modified use of chemotherapy for patients with metastatic breast cancer.
  Hug, V., Clark, J., Johnston, D.> ;Eur J Cancer. 1994
• Dexamethasone mediated stabilization of insulin receptor mRNA.
  Hines, D., Hug, V., Levy, J. R.> ;J Recept Res. 1994 Jul
• Sequence and functional characterization of the terminal exon of the human insulin receptor gene.
  Levy, J. R., Hannah, S., Mooney, R. L., Hug, V., Stevens, W.> ;Biochim Biophys Acta. 1995 Sep 19
• Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.
  Buzdar, A. U., Hortobagyi, G. N., Kau, S. W., Smith, T. L., Fraschini, G., Holmes, F. A., Gutterman, J. U., Hug, V. M., Singletary, S. E., Ames, F. C.> ;J Clin Oncol. 1992 Oct
• Join now to see all